|
Name |
C-15 iturin A
|
Molecular Formula | C49H76N12O14 | |
IUPAC Name* |
3-[(3S,6R,9R,12S,19S,22R,25S)-6,12,22-tris(2-amino-2-oxoethyl)-19-(hydroxymethyl)-9-[(4-hydroxyphenyl)methyl]-16-(9-methylundecyl)-2,5,8,11,14,18,21,24-octaoxo-1,4,7,10,13,17,20,23-octazabicyclo[23.3.0]octacosan-3-yl]propanamide
|
|
SMILES |
CCC(C)CCCCCCCCC1CC(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CO)CC(=O)N)CCC(=O)N)CC(=O)N)CC3=CC=C(C=C3)O)CC(=O)N
|
|
InChI |
InChI=1S/C49H76N12O14/c1-3-27(2)11-8-6-4-5-7-9-12-29-22-42(68)55-33(23-39(51)65)44(70)57-32(21-28-14-16-30(63)17-15-28)43(69)58-34(24-40(52)66)45(71)56-31(18-19-38(50)64)49(75)61-20-10-13-37(61)48(74)59-35(25-41(53)67)46(72)60-36(26-62)47(73)54-29/h14-17,27,29,31-37,62-63H,3-13,18-26H2,1-2H3,(H2,50,64)(H2,51,65)(H2,52,66)(H2,53,67)(H,54,73)(H,55,68)(H,56,71)(H,57,70)(H,58,69)(H,59,74)(H,60,72)/t27?,29?,31-,32+,33-,34+,35+,36-,37-/m0/s1
|
|
InChIKey |
UZIRWCBDDZAYTQ-UROJDDOBSA-N
|
|
Synonyms |
C-15 iturin A; IOW-3; 64642-38-2
|
|
CAS | NA | |
PubChem CID | 101589795 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 1057.2 | ALogp: | -1.3 |
HBD: | 13 | HBA: | 14 |
Rotatable Bonds: | 22 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 437.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 75 | QED Weighted: | 0.052 |
Caco-2 Permeability: | -5.292 | MDCK Permeability: | 0.00004000 |
Pgp-inhibitor: | 0.071 | Pgp-substrate: | 1 |
Human Intestinal Absorption (HIA): | 0.536 | 20% Bioavailability (F20%): | 1 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 52.38% |
Volume Distribution (VD): | 0.393 | Fu: | 35.98% |
CYP1A2-inhibitor: | 0 | CYP1A2-substrate: | 0.002 |
CYP2C19-inhibitor: | 0.01 | CYP2C19-substrate: | 0.017 |
CYP2C9-inhibitor: | 0.125 | CYP2C9-substrate: | 0.031 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.013 |
CYP3A4-inhibitor: | 0.055 | CYP3A4-substrate: | 0.004 |
Clearance (CL): | 1.226 | Half-life (T1/2): | 0.194 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.532 |
Drug-inuced Liver Injury (DILI): | 0.011 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.719 | Maximum Recommended Daily Dose: | 0.689 |
Skin Sensitization: | 0.073 | Carcinogencity: | 0.057 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.002 |
Respiratory Toxicity: | 0.003 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003247 | 0.947 | D09PZZ | 0.469 | ||||
ENC003283 | 0.930 | D0M3FJ | 0.463 | ||||
ENC002094 | 0.930 | D0N4OW | 0.451 | ||||
ENC001950 | 0.915 | D0U7SH | 0.449 | ||||
ENC001506 | 0.776 | D0P4VX | 0.438 | ||||
ENC005271 | 0.527 | D0H3MG | 0.426 | ||||
ENC005273 | 0.480 | D08FJL | 0.410 | ||||
ENC001088 | 0.470 | D09OOV | 0.407 | ||||
ENC005275 | 0.469 | D02SBQ | 0.404 | ||||
ENC005274 | 0.463 | D0J7XL | 0.390 |